News

August 1, 2019

EIP Pharma to Present at Canaccord Genuity 39th Annual Growth Conference

CAMBRIDGE, Mass., August 1, 2019 — EIP Pharma, Inc., a CNS-focused therapeutics company, today announced that company management will present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019, at 12:00 p.m. ET in Boston, MA.

About EIP Pharma
EIP Pharma, Inc. is a private, Cambridge, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases.

For more information, please visit www.eippharma.com.

Contacts:

INVESTORS:

Kevin Sarney
ksarney@eippharma.com

MEDIA:

Arleen Goldenberg
agoldenberg@vergescientific.com

 

About EIP

Are you a patient, caregiver, clinician or professional and want to learn more about EIP Pharma’s approach? Please contact us.

Contact Us